MENU
GRAL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

GRAIL (GRAL) Ownership - Who owns GRAIL?

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection... Show more

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
3.58B
P/E Ratio
N/A
Total Cash
540.13M
Projected Growth
N/A
Total Debt
58.59M
Revenue
141.83M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
13.86
Total Debt/Equity
N/A
Revenue/Share
4.06 USD as % of share price

Fundamentals

GRAL
Capitalization
3.58B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
540M
Total Cash/Share
13.86
Total Debt
58.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.06%
Revenue
142M
ROE
N/A
Book Value
2.24B
P/B Ratio
1.60
Cash Flow
N/A
Earnings
-10.66
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
36K
Current Ratio
7.61
Current Revenue Per Employee
36194.00
Dividends Per Share - Security
N/A
EBITDA
-389.81M
Float
N/A
Float - Current
N/A
Gross Income Margin
-37.94
Revenue To Assets
-14.21
Shares Held By Institutions
4.58B
Shares Outstanding - Current
39M
Total Liabilities
361M
Total Volume MTD
N/A
Value
N/A
Gain YTD
414.622
View a ticker or compare two or three
GRAL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GRAL showed earnings on November 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details